Skip to main content
. 2023 Dec 2;18:378. doi: 10.1186/s13023-023-02983-0

Table 2.

Lung high-resolution computed tomography (HRCT) scores for ground glass appearance

Cross-over from placebo group* Olipudase alfa group**
Baseline n = 18 Olipudase alfa for 1 year n = 14 Baseline n = 18 Year 1 n = 18 Year 2 n = 16
Mean ± SD 0.53 ± 0.64 0.22 ± 0.35 0.65 ± 0.72 0.15 ± 0.29 0.13 ± 0.25
LS mean ± SE change from baseline − 0.37 ± 0.08 − 0.45 ± 0.13 − 0.48 ± 0.07

*Received olipudase alfa for 1 year

**Original olipudase alfa group received olipudase alfa for 2 years

LS least square, SE standard error of the mean